<img height="1" width="1" src="https://www.facebook.com/tr?id=914352225269004&amp;ev=PageView%20&amp;noscript=1">

Postmenopause Study

This medical study aims to determine whether an approved testosterone therapy for women is effective in preventing bone loss and improving libido in postmenopausal women who are taking the standard dose of oestrogen.

Eligibility
  • 18-54 years old
  • Postmenopausal OR had both ovaries removed before 54 years of age
  • Been on a stable dose of hormone replacement therapy (HRT) for at least 3 months
Location

VIC, WA

Duration

Up to 12 months

Read more
MENOPAUSE CIRCLE

If you take part in the research study, there will be:

Reimbursement of costs

For out-of-pocket expenses, such as travel and parking.

Free study-related medical care

You may gain access to new research treatments, before they are widely available.

No overnight stays!

All study visits are out-patient only.

Register your interest now

or scroll down to read the study FAQs

Study Guide

01

Who can take part in this study?

-

In order to be eligible to participate in the study, you must meet all of the following:

  • You are aged between 18 and 54
  • You are postmenopausal OR had both ovaries removed before 54 years of age 
  • You have been on a stable dose of hormone replacement therapy (HRT) for at least 3 months

02

How long will the study take?

+

If you agree to take part, and the study is suitable for you, your participation in the study is expected to last up to 12 months. This may include:

  • Screening period (2-4 weeks): 1 visit to the study centre
  • Treatment period (12 months): Up to 4 visits to the study centre for up to 60-90 minutes at a time.
  • Blood collection and bone density scans at the beginning and end of the trial.
    Some of these visits can be done by telehealth

03

What is the purpose of this study?

+

This study aims to determine whether an approved testosterone therapy for women is effective in preventing bone loss and improving libido in postmenopausal women who are taking the standard dose of oestrogen. Join and do your part to help advance breakthroughs in this clinical research.

04

Why is this study important?

+

1 in 3 women aged 40 - 55  years have low libido, causing them concern.

Women lose bone when they go through menopause, which increases fracture risk.

05

Where is this study being conducted?

+

The Women’s Health Research Program, Monash University 553 St Kilda Rd, Melbourne 3004 (lead centre)

06

What if I have other questions about the study?

+

We are here for you! Click or tap the 'Contact us' button below to send an email to our Patient Experience team:

Contact us



Help make medical research breakthroughs happen.